A change in the initiation of donanemab dosing, shifting one vial of donanemab from the first infusion to the third infusion, lowered ARIA-E to 14% compared to 24% in patients receiving the standard ...

Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022 Based on our observations, it is ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Medical Sciences in which Dr. Ayten Saracoglu and colleagues ...

An 8-week, multicentre (72 sites in the US), double-blind, randomised, parallel group, forced titration study compared the antihypertensive efficacy of candesartan cilexetil and losartan. A total of ...

Objective: To assess and compare healthcare utilization andcosts over a 2-year period in older patients (≥60 years) with type 2diabetes receiving combination therapy with rosiglitazone plus ...

New research presented at the AACE 26th Annual Congress further validates that use of Glytec’s eGlycemic Management System ® eliminates barriers to adoption of basal bolus insulin and produces ...

An 8-week, multicenter, double-blind, randomized, parallel-group, forced-titration study was conducted to evaluate the antihypertensive efficacy of candesartan vs. losartan in 654 hypertensive ...

Single-nucleotide polymorphisms (SNPs) associated with outcomes in patients with localized and metastatic renal cell carcinoma (RCC). This is an ASCO Meeting Abstract from the 2017 Genitourinary ...

A decade ago, the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) updated treatment guidelines for hospital patients outside the intensive care ...

TORONTO, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (CYNA) (CTH.TO), a specialty central nervous system (CNS) pharmaceutical company developing and preparing to commercialize a ...